Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.

Por Møller-Larsen, A, Haahr, S
Publicado em 1978

Physical and psychosocial risk factors for lateral epicondylitis: a population based case-referent study

Por Haahr, J, Andersen, J
Publicado em 2003

A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance

Por Haahr, Hanne, Heise, Tim
Publicado em 2014

Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.

Por Haahr, S, Rasmussen, L, Merigan, T C
Publicado em 1976

Letter: Renal involvement in Henoch-Schönlein purpura.

Por Haahr, J, Thomsen, K, Sparrevohn, S
Publicado em 1974

X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production.

Por Pedersen, E B, Haahr, S, Mogensen, S C
Publicado em 1983

Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.

Por Moller-Larsen, A, Heron, I, Haahr, S
Publicado em 1977

Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus.

Por Møller-Larsen, A, Haahr, S, Heron, I
Publicado em 1978

Interferon in rabbit sera after inoculation with Treponema pallidum suspensions contaminated with PED virus.

Por Fennestad, K L, Bruun, L, Haahr, S
Publicado em 1982

Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

Por Haahr, S, Møller-Larsen, A, Pedersen, E
Publicado em 1983

Altered CD8(+) T cell responses to selected Epstein–Barr virus immunodominant epitopes in patients with multiple sclerosis

Por HÖLLSBERG, P, HANSEN, H J, HAAHR, S
Publicado em 2003

Cellular and Humoral Immune Responses to Herpes Simplex Virus During and After Primary Gingivostomatitis

Por Møller-Larsen, Anné, Haahr, Sven, Black, Finn T.
Publicado em 1978

A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use

Por Haahr, Hanne, Fita, Edmond G., Heise, Tim
Publicado no Clin Pharmacokinet (2016)

Individualized controlled ovarian stimulation in expected poor-responders: an update

Por Haahr, Thor, Esteves, Sandro C., Humaidan, Peter
Publicado no Reprod Biol Endocrinol (2018)

Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across Studies

Por Heise, Tim, Kaplan, Kadriye, Haahr, Hanne L.
Publicado no J Diabetes Sci Technol (2017)

Types of treatment collaboration between conventional and alternative practitioners—results from a research project at a Danish MS hospital

Por Skovgaard, Lasse, Haahr, Niels, Bjerre, Liv, Launsø†, Laila
Publicado em 2010

Understanding the creative processes of phenomenological research: The life philosophy of Løgstrup

Por Norlyk, Annelise, Dreyer, Pia, Haahr, Anita, Martinsen, Bente
Publicado em 2011

Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects

Por Haahr, Hanne, Sasaki, Tomio, Bardtrum, Lars, Ikushima, Ippei
Publicado no J Diabetes Investig (2016)

Cell-mediated and humoral immune responses to herpes simplex virus and cytomegalovirus in renal transplant patients.

Por Haahr, S, Møller-Larsen, A, Andersen, H K, Spencer, E S
Publicado em 1979

Cell-Mediated and Humoral Immunity to Herpesviruses During and After Herpes Zoster Infections

Por Sørensen, Ole S., Haahr, Sven, Møller-Larsen, Anné, Wildenhoff, Kaj
Publicado em 1980